Biocon Biologics
Ashwath Kumar is an experienced Quality Control professional currently serving as an Executive at Biocon Biologics since April 2023, where responsibilities include analysis in the Molecular Biology team utilizing ELISA and PCR techniques, managing laboratory operations, and supporting Quality Management System activities. Prior to this role, Ashwath worked as a Junior Officer at Hetero Biopharma from April 2021 to April 2023 and completed a traineeship in the Quality Control Department at Brilliant Bio Pharma Private Limited from August 2020 to February 2021. Educational qualifications include a Master’s degree in Biotechnology from Manonmaniam Sundaranar University (2017-2019) and a Bachelor’s degree in Biotechnology from Udaya College of Arts and Science (2014-2017).
This person is not in any teams
This person is not in any offices
Biocon Biologics
8 followers
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics